Related references
Note: Only part of the references are listed.Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater
Alyssa D. Rabon et al.
ANNALS OF PHARMACOTHERAPY (2018)
The risk factors of linezolid-induced lactic acidosis A case report and review
Yiyang Mao et al.
MEDICINE (2018)
Assessment of linezolid prescriptions in three French hospitals
C. Dentan et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Predictive score of haematological toxicity in patients treated with linezolid
J. Gonzalez-Del Castillo et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Association of Adverse Events With Antibiotic Use in Hospitalized Patients
Pranita D. Tamma et al.
JAMA INTERNAL MEDICINE (2017)
A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
Federico Pea et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)
High rates of off-label use in antibiotic prescriptions in a context of dramatic resistance increase: a prospective study in a tertiary hospital
Benjamin Davido et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia
Yuki Hanai et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2016)
Context-specific inhibition of translation by ribosomal antibiotics targeting the peptidyl transferase center
James Marks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Association of Off-label Drug Use and Adverse Drug Events in an Adult Population
Tewodros Eguale et al.
JAMA INTERNAL MEDICINE (2016)
Alternative clinical indications for novel antibiotics licensed for skin and soft tissue infection?
Matthew S. Dryden
CURRENT OPINION IN INFECTIOUS DISEASES (2015)
Linezolid-related adverse events predictive score (LAPS): Usefulness in clinical practice
R. Buzele et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Incidence and risk factors of linezolid-induced lactic acidosis
Jae Hyoung Im et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis
T. Ichie et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2015)
Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight
Takashi Niwa et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients
H. -Y. Dong et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Risk factors for linezolid-associated thrombocytopenia in adult patients
B. Natsumoto et al.
INFECTION (2014)
Antimicrobial stewardship and linezolid
Pauline Guillard et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2014)
Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients
Ryuichi Hirano et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2014)
PRACTICE POINTER Serotonin syndrome
Nicholas A. Buckley et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Clinical Relevance of Linezolid-Associated Serotonin Toxicity
Melanie R. Woytowish et al.
ANNALS OF PHARMACOTHERAPY (2013)
High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia
Yoko Nukui et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
Giovanni Sotgiu et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Frequency of the off-label use of antibiotics in clinical practice: a systematic review
Giannoula S. Tansarli et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
Federico Pea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Linezolid: effectiveness and safety for approved and off-label indications
Konstantinos Z. Vardakas et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Linezolid in the treatment of osteomyelitis: Results of compassionate use experience
CR Rayner et al.
INFECTION (2004)
Worldwide assessment of linezolid's clinical safety and tolerability: Comparator-controlled phase III studies
E Rubinstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Safety and tolerability of linezolid
G French
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial
DJ Stalker et al.
CLINICAL PHARMACOKINETICS (2003)
Share Paper
